PHE issues guide on sepsis in children for health visitors and school nurses

PHE issues guide on sepsis in children for health visitors and school nurses

October 10 2017 A new guide setting out information around sepsis in children has been published...

MHRA issues Drug Safety Updates for loperamide and miconazole

MHRA issues Drug Safety Updates for loperamide and miconazole

October 4 2017 The medicines regulator, the MHRA, has issued Drug Safety Updates on two...

Pregnant women are still not being informed of risks associated with sodium valproate

Pregnant women are still not being informed of risks associated with sodium valproate

September 26 2017 Almost a fifth of women with epilepsy (18%) who take sodium valproate are not...

Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

September 25 2017 Users of the Accu-Chek Insight insulin pumps are being asked to check their...

Flu vaccine for 2016-17 season not considered effective in the over 65s age group

Flu vaccine for 2016-17 season not considered effective in the over 65s age group

September 6 2017 Provisional figures for vaccine effectiveness in the 2016-17 flu season have...

  • PHE issues guide on sepsis in children for health visitors and school nurses

    PHE issues guide on sepsis in children for health visitors and school nurses

    Tuesday, 10 October 2017 13:34
  • MHRA issues Drug Safety Updates for loperamide and miconazole

    MHRA issues Drug Safety Updates for loperamide and miconazole

    Wednesday, 04 October 2017 17:04
  • Pregnant women are still not being informed of risks associated with sodium valproate

    Pregnant women are still not being informed of risks associated with sodium valproate

    Tuesday, 26 September 2017 15:51
  • Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

    Accu-Chek Insight insulin pumps in MHRA alert over risk of alarm failure

    Monday, 25 September 2017 14:26
  • Flu vaccine for 2016-17 season not considered effective in the over 65s age group

    Flu vaccine for 2016-17 season not considered effective in the over 65s age group

    Wednesday, 06 September 2017 16:53

vaccinationJune 27 2016

The 2015-16 influenza vaccine effectiveness has been calculated at 57.6% in children and young people aged 2 to 17 years. However, the vaccine effectiveness was 29.1% for adults aged over 65 years.

In its provisional end-of season results for the 2015-16 flu season, Public Health England said that overall influenza vaccine effectiveness was 52.4%, consistent with previous estimates. Vaccine effectiveness among younger adults (18-44 years) was 55.3%, and for those aged 45-64 years was 55.4%.

Children and young people had been given the vaccine by nasal spray (CNSV). PHE noted that “similar evidence of CNSV effectiveness has been reported in Finland, in contrast to the USA where it has been reported that CNSV has been less effective.”

PHE’s latest HPR newsletter points out that in the 2014-15 season when CSNV was piloted among primary school-aged children, “there was not only a 94% reduction in GP influenza-like illness consultation rates in the children themselves (and a 74% reduction in A&E respiratory attendances and a 93% reduction in hospital admissions among children) but also, in the same pilot areas, a 59% reduction in GP consultation rates for ILI in adults, compared to non-pilot areas.”

PHE will publish a fuller report on seasonal flu vaccine effectiveness later in 2016.

Links:

PHE Research and analysis HPR vol 10 issue 20 June 24

PHE Influenza vaccine effectiveness: 2015 to 2016 estimates

PHE provisional data summary

Clinical News

October 20 2017 Recruitment to GP training places in Wales has meant 91% of places were filled in 2017, the Welsh Government has announced. The success means that the recruitment campaign ‘This is...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...